Assess Extent of Disease

Featured Video Play Icon

This content is intended for U.S. Healthcare Providers. Learn through a case based discussion featuring Dr. Gary Ulaner, James & Pamela Muzzy Endowed Chair of Molecular Imaging & Therapy at Hoag Family Cancer Institute, how Cerianna™ (fluoroestradiol F 18) injection may help assess the extent of metastatic ER+ lesions in invasive lobular breast cancer (ILC).​

Next Post

Entrepreneurs Utilize Technology To Build The Future Of Healthcare With Preventative Products And Services

Across the spectrum of care, we now see more empowered health-seeking consumers who want access to better healthcare. And that also includes transparency of costs, access to personal health records for self-improvement, and chronic disease monitoring. As consumer behavior and preferences continue to change, we need the digital healthcare landscape […]